Ontology highlight
ABSTRACT:
SUBMITTER: Menzella F
PROVIDER: S-EPMC5933597 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Therapeutic advances in respiratory disease 20160909 6
Despite several therapeutic choices, 10-20% of patients with severe uncontrolled asthma do not respond to maximal best standard treatments, leading to a healthcare expenditure of up to 80% of overall costs for asthma. Today, there are new important therapeutic strategies, both pharmacological and interventional, that can result in improvement of severe asthma management, such as omalizumab, bronchial thermoplasty and other biological drugs, for example, mepolizumab, reslizumab and benralizumab. ...[more]